<scp>Ultrasound‐Guided</scp> Breast Biopsies

Bhatt, Asha A; Whaley, Dana H.; Lee, Christine

doi:10.1002/jum.15517

Cited by 11 publications

(9 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This might be because the lesion near the nipple was removed relatively conservatively for fear of damaging the nipple, therefore leading to a small number of residual tumor cells, and then resulting in recurrence. Hydrodissection might be helpful to reduce recurrence by injecting saline or lidocaine between the lesion and the nipple to displace the lesion away from the nipple to protect the nipple at the time of US‐guided VAE [21]. However, the data are small and a larger sample is needed to verify this conclusion.…”

Section: Discussionmentioning

confidence: 99%

“…The recurrence rate of lesions with distance from nipple of less than 1 cm was significantly higher than that of lesions with distance from nipple of more than 1 cm (75% vs. 10%, p \ 0.05) in this study. This might be because the lesion near the nipple was removed relatively conservatively for fear of damaging the nipple, therefore leading to a small number of Hydrodissection might be helpful to reduce recurrence by injecting saline or lidocaine between the lesion and the nipple to displace the lesion away from the nipple to protect the nipple at the time of US-guided VAE [21]. However, the data are small and a larger sample is needed to verify this conclusion.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

High‐Risk Breast Lesions Diagnosed by Ultrasound‐Guided Vacuum‐Assisted Excision

Lei

Zhao

et al. 2023

World j. surg.

View full text Add to dashboard Cite

Purpose The aim of this study was to analyze the role of ultrasound‐guided vacuum‐assisted excision (US‐guided VAE) in the treatment of high‐risk breast lesions and to evaluate the clinical and US features of the patients associated with recurrence or development of malignancy. Materials and methods Between April 2010 and September 2021, 73 lesions of 73 patients underwent US‐guided VAE and were diagnosed with high‐risk breast lesions. The incidence of recurrence or development of malignancy for high‐risk breast lesions was evaluated at follow‐up period. The clinical and US features of the patients were analyzed to identify the factors affecting the recurrence or development of malignancy rate. Results Only benign phyllodes tumors on US‐guided VAE showed recurrences, while other high‐risk breast lesions that were atypical ductal hyperplasia (ADH), lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ), radial scar, and flat epithelial atypia did not show recurrences or malignant transformation. The recurrence rate of the benign phyllodes tumor was 20.8% (5/24) in a mean follow‐up period of 34.3 months. The recurrence rate of benign phyllodes tumor with distance from nipple of less than 1 cm was significantly higher than that of lesions with distance from nipple of more than 1 cm (75% vs. 10%, p < 0.05). Conclusions Benign phyllodes tumors without concurrent breast cancer could be safely followed up instead of surgical excision after US‐guided VAE when the lesions were classified as BI‐RADS 3 or 4A by US.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

High‐Risk Breast Lesions Diagnosed by Ultrasound‐Guided Vacuum‐Assisted Excision

Lei

Zhao

et al. 2023

World j. surg.

View full text Add to dashboard Cite

show abstract

“…The physician needs to visualize the needle in real-time while performing the ultrasound imaging to ensure that the needle will hit the targeted lesion [ 33 ]. In this work, strategies were implemented to assist the user in aligning the biopsy needle with the US image plane.…”

Section: Methodsmentioning

confidence: 99%

Augmented Reality-Assisted Ultrasound Breast Biopsy

Costa

Ferreira

Araújo

et al. 2023

Sensors

View full text Add to dashboard Cite

Breast cancer is the most prevalent cancer in the world and the fifth-leading cause of cancer-related death. Treatment is effective in the early stages. Thus, a need to screen considerable portions of the population is crucial. When the screening procedure uncovers a suspect lesion, a biopsy is performed to assess its potential for malignancy. This procedure is usually performed using real-time Ultrasound (US) imaging. This work proposes a visualization system for US breast biopsy. It consists of an application running on AR glasses that interact with a computer application. The AR glasses track the position of QR codes mounted on an US probe and a biopsy needle. US images are shown in the user’s field of view with enhanced lesion visualization and needle trajectory. To validate the system, latency of the transmission of US images was evaluated. Usability assessment compared our proposed prototype with a traditional approach with different users. It showed that needle alignment was more precise, with 92.67 ± 2.32° in our prototype versus 89.99 ± 37.49° in a traditional system. The users also reached the lesion more accurately. Overall, the proposed solution presents promising results, and the use of AR glasses as a tracking and visualization device exhibited good performance.

show abstract

“…Mammography and ultrasound are the minimum propaedeutics for the evaluation of breast lesions. (6) Mammography is not necessary in patients under 30 years of age, especially in those under 25 years of age with nodules suggestive of benign BI-RADS category 3.…”

Section: Imaging Propaedeuticsmentioning

confidence: 99%

“…Mammography and ultrasound are the minimum propaedeutics for the evaluation of breast lesions. 6 Mammography is not necessary in patients under 30 years of age, especially in those under 25 years of age with nodules suggestive of benign BI-RADS category 3. Tomosynthesis can be particularly useful in the assessment of breasts lesions with density pattern B (sparse areas of fibroglandular tissue) and C (heterogeneously dense) according to the BI-RADS classification.…”

Section: Imaging Propaedeuticsmentioning

confidence: 99%